Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wart war: which treatment wins – acid, fungus extract, or both?

NCT ID NCT07329907

Disease control Sponsor: Benha University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This study tested three ways to treat warts: a topical acid solution, injections of candida antigen (a yeast extract), and a combination of both. 126 people with warts took part. The goal was to see which approach cleared warts best, including warts not directly treated, and how often they came back. Results will help doctors choose the most effective option.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
salicylic acid/lactic acid topical solution and candida antigen injection
What this could lead to
If successful, this could point toward a more effective, affordable treatment for warts that clears both treated and distant warts.
What could go wrong
This is a small, completed Phase 2 trial, so results may not apply to everyone. Warts can recur, and treatments may cause pain or skin reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

126 people

The number who actually took part.

Started

Dec 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Single or multiple warts. 2. Aged 5 to 60 years. 3. Eligible for both topical and intralesional treatments. 4. No prior wart treatment for at least 1 month. Exclusion Criteria: 1. Pregnancy or lactation. 2. Immunosuppression or use of immunosuppressive drugs. 3. Known sensitivity to study ingredients. 4. Systemic/local inflammation or infection. 5. History of bleeding/clotting disorder, or use of anticoagulants/NSAIDs. 6. History of asthma, allergic skin disorders, or convulsions. 7. History of chronic systemic diseases (renal/hepatic failure, cardiovascular disorders).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Human papilloma virus (HPV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

common wart human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Human papilloma virus (HPV) Warts

Contacts and locations

Locations

  • Outpatient Clinic of Dermatology, Venereology and Andrology Department at Benha University Hospitals

    Banhā, Qalyubia Governorate, 13518, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.